Hua Medicine (OTCPK:HUMDF)
$ 0.2028 0 (0%) Market Cap: 150.90 Mil Enterprise Value: -30.63 Mil PE Ratio: 0 PB Ratio: 10.18 GF Score: 35/100

Hua Medicine at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 11:30AM GMT
Unidentified Analyst

Good morning, and thank you for coming to the 2020 Virtual UBS Global Healthcare Conference. My name is [Brandon], and I'm happy to be your host for this session. Our next presenter will be George Lin, Executive Vice President and Chief Financial Officer of Hua Medicine. A Q&A session will follow immediately after the presentation. To submit a question anonymously to be answered at the end of the session, please type your question in the Q&A prompt on the presentation screen. We now turn it over to George. Thank you.

Chien Cheng Lin;Shanghai;Ltd.;Executive VP
Hua Medicine;CFO & Executive Director

()- -

Great. Thanks, [Brandon], and thanks, everyone, for the interest in Hua Medicine. I will give a short company presentation, which you should have access to. I will go through the -- I won't go through the disclaimer. The disclaimer you can see is right there, and I'll start on Page 4.

Hua Medicine is a publicly listed company in the Hong Kong Stock Exchange under the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot